Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.
This report contains market size and forecasts of Biliary Atresia Treatment in Global, including the following market information:
Global Biliary Atresia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biliary Atresia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biliary Atresia Treatment include AstraZeneca, Daiichi Sankyo, Eisai, Johnson & Johnson, Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biliary Atresia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biliary Atresia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biliary Atresia Treatment Market Segment Percentages, by Type, 2021 (%)
Drug Treatment
Surgery Treatment
Global Biliary Atresia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biliary Atresia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Biliary Atresia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biliary Atresia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biliary Atresia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biliary Atresia Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Daiichi Sankyo
Eisai
Johnson & Johnson
Novartis
Pfizer